Mediterranean spotted fever in pregnancy

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 2, 1999, Pages 202-203

  Cohen, Joel ^a   Lasri, Yechiel ^a   Landau, Zvi ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; RIFAMPICIN;

ADULT; ARTICLE; BOUTONNEUSE FEVER; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; PREGNANCY; RICKETTSIA CONORII;

ADULT; ANTI-BACTERIAL AGENTS; BOUTONNEUSE FEVER; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RICKETTSIA CONORII; RIFAMPIN; TREATMENT OUTCOME;

EID: 0032857592     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655499750006290     Document Type: Article

References (7)

1. Gallis HA, Agner RC, Painter CJ. Rocky Mountain spotted fever in pregnancy. NC Med J 1984; 45: 187-8.
2. Sexton DJ, Dwyer B, Kemp R, Graves S. Spotted fever group rickettsial infections in Australia. Rev Infect Dis 1991; 13: 876-86.
3. Raoult D, Rancourt M. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother 1991; 35: 2457-62.
4. Herbert WNP, Seeds JW, Koontz WL, Cefalo RC. Rocky Mountain spotted fever in pregnancy: differential diagnosis and treatment. South Med J 1982; 75: 1063-6.
5. Schwartz R. Considerations of antibiotic therapy during pregnancy. Obstet Gynecol 1981; 58 Suppl 5: 95S-99S.
6. Raoult D, Roussellier Q, Verstris G, Tamalet J. In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J Infect Dis 1987; 155: 1059-62.
7. Bella F, Espejo E, Uriz S, Serrano J, Alegre M. Tort J. Randomized trial of 5-day rifampin versus 1-day doxycycline therapy for Mediterranean spotted fever. J Infect Dis 1991; 164: 433-4.